Vivos therapeutics announces receipt of notice from nasdaq regarding late filing of quarterly report on form 10-q

Littleton, colo., aug. 26, 2022 (globe newswire) -- vivos therapeutics, inc. (nasdaq: vvos) (“vivos” or the “company”) today announced that it has received a notice (“notice”) from the listing qualifications department of the nasdaq stock market (“nasdaq”) notifying the company that it was not in compliance with requirements of nasdaq listing rule 5250(c)(1) as a result of not having timely filed its quarterly report on form 10-q for the quarter ended june 30, 2022 (the “form 10-q”).
VVOS Ratings Summary
VVOS Quant Ranking